TriHealth Inc.

Quick facts

Marketed products

• Estradiol 0.01% Vag Cream · Gynecology / Women's Health
  Estradiol binds to estrogen receptors in vaginal tissue to restore local estrogen levels and alleviate symptoms of vaginal atrophy and genitourinary syndrome of menopause.
• Lidocaine alone · Anesthesia / Pain Management
  Lidocaine blocks sodium channels in nerve cell membranes, preventing the initiation and conduction of nerve impulses to produce local anesthesia.
• Lidocaine Ropivacaine · Anesthesia
  This combination of lidocaine and ropivacaine blocks sodium channels in nerve cell membranes to produce local anesthesia.
• local infiltration of liposomal bupivacaine · Anesthesia / Pain Management
  Liposomal bupivacaine is a local anesthetic that blocks sodium channels in nerve cell membranes to prevent pain signal transmission, with extended duration due to liposomal encapsulation.
• Saline-only catheter flush · Medical Device/Vascular Access
  Saline-only catheter flush maintains catheter patency and prevents thrombosis by delivering sterile normal saline through the catheter lumen without anticoagulant or antimicrobial additives.

Phase 3 pipeline

• Bupivacaine-Meloxicam · Pain Management / Anesthesia
  Bupivacaine-Meloxicam is a combination of a local anesthetic and a nonsteroidal anti-inflammatory drug designed to provide prolonged pain relief and reduce inflammation at the injection site.
• Vaginal conjugated estrogen cream 0.5gm · Women's Health
  Estrogen replacement therapy to alleviate menopausal symptoms.
• Vaginal conjugated estrogen cream 1.0gm · Women's Health
  Estrogen replacement therapy to alleviate menopausal symptoms.

Phase 1 pipeline

• Dilaudid IV Scheduled
• Dilaudid PCA
• Vaginal Diazepam Suppository

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• TriHealth Inc. portfolio CI brief
• TriHealth Inc. pipeline updates RSS